{"title":"对 \"miR-203 抑制促进再生肝脏中残留肝细胞癌的增殖和转移 \"的更正。","authors":"","doi":"10.1111/cas.16361","DOIUrl":null,"url":null,"abstract":"<p>Zheng XB, Chen XB, Xu LL, Zhang M, Feng L, Yi PS, Tang JW, Xu MQ. miR-203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver. Cancer Sci 2017; 108 (3): 338–346.</p><p>In Figure 3A, an incorrect image was used to show Ki67 expression in HCC tissue of the PH group. Furthermore, the Tubulin alpha western blot was incorrectly labeled in figure 5B.</p><p>The authors apologize for these errors.</p>","PeriodicalId":9580,"journal":{"name":"Cancer Science","volume":"116 1","pages":"278"},"PeriodicalIF":4.5000,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11711051/pdf/","citationCount":"0","resultStr":"{\"title\":\"Correction to “miR-203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver”\",\"authors\":\"\",\"doi\":\"10.1111/cas.16361\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Zheng XB, Chen XB, Xu LL, Zhang M, Feng L, Yi PS, Tang JW, Xu MQ. miR-203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver. Cancer Sci 2017; 108 (3): 338–346.</p><p>In Figure 3A, an incorrect image was used to show Ki67 expression in HCC tissue of the PH group. Furthermore, the Tubulin alpha western blot was incorrectly labeled in figure 5B.</p><p>The authors apologize for these errors.</p>\",\"PeriodicalId\":9580,\"journal\":{\"name\":\"Cancer Science\",\"volume\":\"116 1\",\"pages\":\"278\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2024-10-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11711051/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Science\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/cas.16361\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Science","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cas.16361","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
Correction to “miR-203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver”
Zheng XB, Chen XB, Xu LL, Zhang M, Feng L, Yi PS, Tang JW, Xu MQ. miR-203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver. Cancer Sci 2017; 108 (3): 338–346.
In Figure 3A, an incorrect image was used to show Ki67 expression in HCC tissue of the PH group. Furthermore, the Tubulin alpha western blot was incorrectly labeled in figure 5B.
期刊介绍:
Cancer Science (formerly Japanese Journal of Cancer Research) is a monthly publication of the Japanese Cancer Association. First published in 1907, the Journal continues to publish original articles, editorials, and letters to the editor, describing original research in the fields of basic, translational and clinical cancer research. The Journal also accepts reports and case reports.
Cancer Science aims to present highly significant and timely findings that have a significant clinical impact on oncologists or that may alter the disease concept of a tumor. The Journal will not publish case reports that describe a rare tumor or condition without new findings to be added to previous reports; combination of different tumors without new suggestive findings for oncological research; remarkable effect of already known treatments without suggestive data to explain the exceptional result. Review articles may also be published.